Mesoblast Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MESO | SLDB | 7776.T | LCTX | 4880.T | RXRX | |
|---|---|---|---|---|---|---|
| Market cap | 1.86B | 699.11M | 6.78B | 260.49M | 5.76B | 2.42B |
| P/E (TTM) | — | — | — | — | 58.4 | — |
| Forward P/E | 31.4 | -3.8 | — | -7.5 | 16.1 | -4.5 |
| Price/book | 3.3 | 2.9 | 3.0 | 4.3 | 1.0 | 2.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −4.29% | +54.69% | −57.71% | −40.46% | −42.83% | −25.81% |
| Today | −3.25% | +3.82% | −4.97% | +1.98% | +3.94% | +5.43% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All MESO news ›Mesoblast (OTCMKTS:MEOBF) Stock Falls 13.9% – Here’s What Happened
Posted by Kim Johansen on Nov 5th, 2026 Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report)’s stock price was down 13.9% during mid-day trading on Wednesday. The company traded as low as $1.14 and last traded at $1.14. 500 shares were…
Mesoblast Stock Jumps 17% on Nasdaq as Ryoncil Sales Climb 44% and Cash Burn Collapses in Quarterly Update
Mesoblast shares jumped more than 17% on the Nasdaq in early trading Thursday. U.S. investors joined a rally in Australia after the cell therapy company reported strong growth in sales of its flagship drug Ryoncil and a sharp drop in cash…
Should I buy Cochlear and Mesoblast shares with $5,000?
These two companies are at different stages of their growth journeys. Here's which I'd choose for a long-term investment. Her work focuses on making complex financial ideas clear, practical, and engaging for everyday investors. She has a…
Why are Mesoblast shares racing 15% higher today?
Find out what caught investor interest. Samantha Menzies is a writer and editor with close to 20 years' experience covering finance, investing, business and property in Australia and the UK. She has held senior editorial roles at Yahoo…
Max Meta: Dynamax Mesprit – Stuck In The Middle Of Its Siblings
Dynamax Mesprit is one of the Lake Trio Legendary Pokémon that debuted on October 24, 2026, alongside Azelf and Uxie. All three debuted in their respective regions, with Mesprit appearing in Europe, the Middle East, Africa, and India. The…
Mesoblast Shares At The Foot of ASX 200 Today, In Lowest Close Of The Year
Mesoblast shares (ASX:MSB) fell sharply today, as markets continue to work through its preliminary first-quarter results. The Mesoblast share price closed out the opening trading session of the week down 11.06% at A$1.77, their lowest…
Mesoblast Shares Bounce Back From Lows To Lead ASX 200 Today
Mesoblast shares (ASX: MSB) put up a solid recovery today, with the stock climbing 5.68% to close at A$1.86, fresh off 52-week lows of A$1.74. Today’s ASX 200 leading performance will be welcome news for holders who have seen shares tumble…
Mesoblast: Ryoncil Helps Fund Rexlemestrocel-L For Back Pain
Mesoblast's Ryoncil provides commercial validation for its cell-therapy platform while helping finance additional development. Learn more about MESO stock here. - Mesoblast's Ryoncil provides commercial validation for its cell-therapy…
Buy, hold, sell: Mesoblast, PLS, and SEEK shares
Bell Potter has given its verdict on these shares this week. If you are in the market for some new portfolio additions, it could be worth seeing what the team at Bell Potter is saying about the three ASX shares in this article. Does the…
Mesoblast Reports Strong Q1 FY26 with Soaring Ryoncil® Revenue and Improved Cash Position
Mesoblast Limited (ASX:MSB), a global leader in allogeneic cellular medicines for inflammatory diseases, develops off-the-shelf cellular therapies designed to counter and modulate severe inflammation. The company today reported a…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- fool.com.au5
- kalkinemedia.com4
- stocktitan.net3
- thebull.com.au2
- defenseworld.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 19 articles, not a forecast.